Yamagishi Yoshiaki, Togawa Masao, Shiomi Masashi
Department of Pediatrics, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Pediatr Int. 2009 Jun;51(3):371-6. doi: 10.1111/j.1442-200X.2008.02740.x. Epub 2008 Nov 19.
The aim of the present study was to describe the clinical features of septic arthritis (SA) and acute hematogenous osteomyelitis (AHO) in children and to assess the impact of health-care-associated infections and antimicrobial resistance.
A retrospective review of medical records of children presenting to Osaka City General Hospital with SA and AHO was undertaken during an 85 month period. The following data were assessed: location at onset, age and gender, risk factors, involved joints and/or bones, symptoms and time of presentation, causative agents and sensitivity to antibiotics, treatments and late complications.
There were four health-care-associated (HCAI) and 20 community-acquired infections (CAI). The latency period from initial presentation to diagnosis was relatively longer in HCAI than CAI. The most common pathogen was methicillin-resistant Staphylococcus aureus (MRSA). Twenty percent of CAI patients and half of the HCAI patients were treated empirically for MRSA. All patients with complications had MRSA infection.
Many pediatric patients with SA were not treated initially with optimal antibiotics. Although surgical intervention was almost inevitably required, selection and administration of effective antibiotics was necessary not only to cure the current infection but also to prevent metastatic infection. In Japan, empiric treatment of SA and AHO should include first-line antibiotics against MRSA.
本研究旨在描述儿童脓毒性关节炎(SA)和急性血源性骨髓炎(AHO)的临床特征,并评估医疗保健相关感染和抗菌药物耐药性的影响。
对大阪市立医院在85个月期间收治的患有SA和AHO的儿童病历进行回顾性研究。评估以下数据:发病部位、年龄和性别、危险因素、受累关节和/或骨骼、症状及就诊时间、病原体及对抗生素的敏感性、治疗方法及晚期并发症。
有4例医疗保健相关感染(HCAI)和20例社区获得性感染(CAI)。HCAI从首次就诊到诊断的潜伏期比CAI相对更长。最常见的病原体是耐甲氧西林金黄色葡萄球菌(MRSA)。20%的CAI患者和半数HCAI患者接受了针对MRSA的经验性治疗。所有有并发症的患者均为MRSA感染。
许多患有SA的儿科患者最初未接受最佳抗生素治疗。尽管几乎不可避免地需要手术干预,但选择和使用有效的抗生素不仅对于治愈当前感染而且对于预防转移性感染都是必要的。在日本,SA和AHO的经验性治疗应包括针对MRSA的一线抗生素。